Systemic and spinal analgesic activity of a δ-opioid-selective lanthionine enkephalin analog

Journal of Pharmacology and Experimental Therapeutics

Volumn 304, Issue 2, 2003, Pages 827-832

  Svensson, Camilla I ^a   Rew, Yosup ^b   Malkmus, Shelle ^a   Schiller, Peter W ^c   Taulane, Joseph P ^b   Goodman, Murray ^b   Yaksh, Tony L ^a  

^a University of California   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c CLIN RESEARCH INSTITUTE OF MONTREAL   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

AMINO ACID; DELTA OPIATE RECEPTOR; DELTA OPIATE RECEPTOR ANTAGONIST; DEXTRO PHENYLALANYLCYSTEINYLTYROSYL DEXTRO TRYPTOPHYLORNITHYLTHREONYLPENICILLAMINYLTHREONINAMIDE 2,7 DISULFIDE; ENKEPHALIN DERIVATIVE; ENKEPHALIN[2,5 DEXTRO PENICILLAMINE]; LANTHIONINE; LANTHIONINE ENKEPHALIN DERIVATIVE; LEUCINE ENKEPHALIN; MORPHINE; MU OPIATE RECEPTOR; MU OPIATE RECEPTOR ANTAGONIST; NALOXONE; NALTRINDOLE; SULFIDE; TYROSYL CYCLO(DEXTRO VALYLGLYCYLPHENYLALANYL DEXTRO ALANYL); UNCLASSIFIED DRUG;

ANALGESIA; ANALGESIC ACTIVITY; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BEHAVIOR; CONTROLLED STUDY; DOSE RESPONSE; DRUG ANTAGONISM; DRUG POTENCY; DRUG RECEPTOR BINDING; DRUG SELECTIVITY; DRUG STRUCTURE; DRUG SYNTHESIS; ENZYMATIC DEGRADATION; GUINEA PIG; ILEUM; MALE; MOTOR PERFORMANCE; MOUSE; NONHUMAN; PRIORITY JOURNAL; RAT; SPINE; VAS DEFERENS;

ALANINE; ANALGESICS, OPIOID; ANIMALS; DOSE-RESPONSE RELATIONSHIP, DRUG; ENKEPHALIN, D-PENICILLAMINE (2,5)-; ENKEPHALINS; GUINEA PIGS; MALE; MICE; PAIN MEASUREMENT; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, OPIOID, DELTA; SPINAL CORD; SULFIDES;

EID: 0037309415     PISSN: 00223565     EISSN: None     Source Type: Journal    
DOI: 10.1124/jpet.102.039750     Document Type: Article

References (34)

1. Baker TJ, Rew Y, and Goodman M (2000) Novel reagents and reactions for drug design. Pure Appl Chem 72:347-354.
2. Berman JM, Goodman M, Nguyen TM, and Schiller PW (1983) Cyclic and acyclic partial retro-inverso enkephalinamides: μ receptor selective enzyme resistant analogs. Biochem Biophys Res Commun 115:864-870.
3. Besse D, Lombard MC, Zajac JM, Roques BP, and Besson JM (1990) Pre- and postsynaptic distribution of μ, δ, and κ opioid receptors in the superficial layers of the cervical dorsal horn of the rat spinal cord. Brain Res 521:15-22.
4. Bilsky EJ, Calderon SN, Wang T, Bernstein RN, Davis P, Hruby VJ, McNutt RW, Rothman RB, Rice KC, and Porreca F (1995) SNC 80, a selective, nonpeptidic and systemically active opioid δ agonist. J Pharmacol Exp Ther 273:359-366.
5. Bloomfield SS, Barden TP, and Mitchell J (1983) Metkephamid and meperidine analgesia after episiotomy. Clin Pharmacol Ther 34:240-247.
6. Chang KJ, Rigdon GC, Howard JL, and McNutt RW (1993) A novel, potent and selective nonpeptidic δ opioid receptor agonist BW373U86. J Pharmacol Exp Ther 267:852-857.
7. Dickenson AH, Sullivan AF, Knox R, Zajac JM, and Roques BP (1987) Opioid receptor subtypes in the rat spinal cord: electrophysiological studies with μ- and δ-opioid receptor agonists in the control of nociception. Brain Res 413:36-44.
8. Dirig DM, Salami A, Rathbun ML, Ozaki GT, and Yaksh TL (1997) Characterization of variables defining hindpaw withdrawal latency evoked by radiant thermal stimuli. J Neurosci Methods 76:183-191.
9. 5]-enkephalin in the rat. J Pharmacol Exp Ther 259:725-731.
10. Frederickson RC, Parli CJ, DeVane GW, and Hynes MD (1983) Preclinical pharmacology of metkephamid (LY127623), a Met-enkephalin analogue. NIDA Res Monogr 43:150-156.
11. Goodman M, Zapf C, and Rew Y (2001) New reagents, reactions and peptidomimetics for drug design. Biopolymers 60:229-245.
12. Hambrook JM, Morgan BA, Rance MJ, and Smith CF (1976) Mode of deactivation of the enkephalins by rat and human plasma and rat brain homogenates. Nature (Lond) 262:782-783.
13. 5]enkephalin. J Med Chem 35:684-687.
14. Hargreaves K, Dubner R, Brown F, Flores C, and Joris J (1988) A new and sensitive method for measuring thermal nociception in cutaneous hyperalgesia. Pain 32:77-88.
15. Henderson G, Hughes J, and Kosterlitz HW (1972) A new example of a morphine-sensitive neuro-effector junction: adrenergic transmission in the mouse vas deferens. Br J Pharmacol 46:764-766.
16. Hui K-S, Wang Y-J, Wong K-H, Tsai H, and Lajtha A (1981) Regional and subcellular distribution of Met- and Leu-enkephalin-degrading activity in rat brain. Neuropeptides (Edinburgh) 1:167-173.
17. Lord JA, Waterfield AA, Hughes J, and Kosterlitz HW (1977) Endogenous opioid peptides: multiple agonists and receptors. Nature (Lond) 267:495-499.
18. Marks N, Grynabaum A, and Neidle A (1977) On the degradation of enkephalins and endorphins by rat and mouse brain extracts. Biochem Biophys Res Commun 74:1552-1559.
19. 5-enkephalin in cancer patients with chronic pain. Pain 23:213-221.
20. Nagasaka H, Awad H, and Yaksh TL (1996) Peripheral and spinal actions of opioids in the blockade of the autonomic response evoked by compression of the inflamed knee joint. Anesthesiology 85:808-816.
21. Onofrio BM and Yaksh TL (1983) Intrathecal δ-receptor ligand produces analgesia in man. Lancet 1:1386-1387.
22. Paton WDM (1957) The action of morphine and related substances on contraction and acetylcholine output of coaxially stimulated guinea-pig ileum. Br J Pharmacol 12:119-127.
23. 5]-enkephalin in the mouse. J Pharmacol Exp Ther 241:393-400.
24. Rew Y, Malkmus S, Svensson C, Yaksh TL, Chung NN, Schiller PW, Cassel JA, DeHaven RN, and Goodman M (2002) Synthesis and biological activities of cyclic lanthionine enkephalin analogues: δ-opioid receptor selective ligands. J Med Chem 45:3746-3754.
25. Shibanoki S, Weinberger SB, Schulteis G, Ishikawa K, and Martinez JL Jr (1992) Enkephalin hydrolysis by mouse plasma in vitro. Life Sci 50:667-675.
26. 5-enkephalin (DADLE) cross-tolerance after continuous intrathecal infusion in the rat. Anesthesiology 76:596-603.
27. Taki Y, Sakane T, Nadai T, Sezaki H, Amidon GL, Langguth P, and Yamashita S (1998) First-pass metabolism of peptide drugs in rat perfused liver. J Pharm Pharmacol 50:1013-1018.
28. Tseng LF, Narita M, Mizoguchi H, Kawai K, Mizusuna A, Kamei J, Suzuki T, and Nagase H (1997) δ1 opioid receptor-mediated antinociceptive properties of a non-peptidic δ opioid receptor agonist, (-)TAN-67, in the mouse spinal cord. J Pharmacol Exp Ther 280:600-605.
29. Tung AS and Yaksh TL (1982) In vivo evidence for multiple opiate receptors mediating analgesia in the rat spinal cord. Brain Res 247:75-83.
30. Wang SHH (1996) Studies of lanthionine peptides and the use of urethane-protected N-carboxyanhydrides in solid phase peptide synthesis, in Chemistry and Biochemistry, pp 77-106, University of California Press, San Diego, CA.
31. Wang SHH, Bahmanyar S, Taulane JP, and Goodman M (1996) Enzymic stability of disulfide-bridged peptides and their lanthionine analogs, in Peptides: Chemistry, Structure and Biology (Proceedings of the 14th American Peptide Symposium) (Kumaya PTP and Hodges RS eds) pp 715-716, Mayflower Scientific, Kingswinford, UK.
32. Yaksh TL (1997) Pharmacology and mechanisms of opioid analgesic activity. Acta Anaesthesiol Scand 41:94-111.
33. Yaksh TL, Malmberg AB, Ro S, Schiller P, and Goodman M (1995) Characterization of the spinal antinociceptive activity of constrained peptidomimetic opioids. J Pharmacol Exp Ther 275:63-72.
34. Yaksh TL and Rudy TA (1976) Chronic catheterization of the spinal subarachnoid space. Physiol Behav 17:1031-1036.